"10.1371_journal.pone.0094272","plos one","2014-04-04T00:00:00Z","Marisa Zallocchi; Katie Binley; Yatish Lad; Scott Ellis; Peter Widdowson; Sharifah Iqball; Vicky Scripps; Michelle Kelleher; Julie Loader; James Miskin; You-Wei Peng; Wei-Min Wang; Linda Cheung; Duane Delimont; Kyriacos A Mitrophanous; Dominic Cosgrove","Boys Town National Research Hospital, Omaha, Nebraska, United States of America; Oxford BioMedica (UK) Ltd, Oxford Science Park, Oxford, United Kingdom; University of Nebraska Medical Center, Omaha, Nebraska, United States of America","Conceived and designed the experiments: DC MZ KB SE YL PW. Performed the experiments: MZ PW SI VS MK JL Y-WP JM W-MW LC DD KAM. Analyzed the data: DC MZ KB TL SE. Contributed reagents/materials/analysis tools: PW SI VC MK JL KAM. Wrote the paper: DC MZ KB YL SE.","Katie Binley, Yatish Lad, Scott Ellis, Peter Widdowson, Sharifah Iqball, Vicky Scripps, Michelle Kelleher, Julie Loader, James Miskin and Kyriacos A. Mitrophanous are employed by Oxford BioMedica which has a financial interest in the development of the gene therapy vector under development, which is currently in human clinical trials. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","04","Marisa Zallocchi","MZ",16,TRUE,6,12,5,5,TRUE,TRUE,FALSE,0,NA,FALSE
